Court, Angela C.
Parra-Crisóstomo, Eliseo
Castro-Córdova, Pablo
Abdo, Luiza
Aragão, Emmanuel Arthur Albuquerque
Lorca, Rocío
Figueroa, Fernando E.
Bonamino, Martín Hernán
Khoury, Maroun http://orcid.org/0000-0002-9965-6266
Funding for this research was provided by:
Agencia Nacional de Investigación y Desarrollo (Fondecyt Regular 1211749, FONDECYT Iniciación 11240539)
Basal Funding for Scientific and Technological Center of Excellence (FB210024)
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
Article History
Received: 12 February 2024
Accepted: 14 August 2024
First Online: 27 September 2024
Declarations
:
: All the procedures presented in this work were approved by the Ethics Committee of Universidad de los Andes, Chile (#CEC202729) and the Ethics Committee of the Brazilian National Cancer Institute (CEP-INCA)—51589521.4.0000.5274.
: Not applicable.
: Maroun Khoury is the CEO and CSO of Cells for Cells and Regenero. Angela Court received stipend from Regenero. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.